Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Ospexin Suspension 375mg


May be acceptable
Use with caution

May be acceptable
Use with caution
Ospexin Suspension 375mg :
Type Medicine Non Marketed
Originator G
Agent Mersaco
Distributor Mersaco
Laboratory Sandoz
Responsible Party Sandoz GmbH
Origin Austria
Manufacturer Sandoz GmbH
Manufacturing Type G
Origin Austria
ATC J01DB01

Your comment will appear shortly after approval

Ospexin Suspension 375mg :

Revision Date : 01/03/2011


Effect Frequency
Abdominal pain Not known
Agitation Not known
ALT increased Not known
Anal pruritus Not known
Anaphylaxis Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Uncommon
Arthralgia (Pain joint) (Joint ache) Not known
Arthritis Not known
AST increased Not known
Confusion Not known
Diarrhoea (Diarrhea) Common
Dizziness Not known
Dyspepsia Not known
Eosinophilia Not known
Erythema multiforme Rare
Fatigue Not known
Genital candidiasis Not known
Haemolytic anemia Not known
Hallucination Not known
Headache Not known
Hepatitis Rare
Interstitial nephritis Rare
Jaundice cholestatic (Cholestatic icterus) Rare
Joint disorders Not known
Lyell Syndrome (Toxic epidermal necrolysis) Rare
Nausea Rare
Neutropenia Not known
Pruritus genital Not known
Pseudomembranous colitis Not known
Skin rash Uncommon
Stevens-Johnson syndrome Rare
Thrombocytopenia (Thrombopenia) Not known
Urticaria Uncommon
Vaginal discharge Not known
Vaginitis Not known
Vomiting Rare

Different Units By MoH Code

Ospexin Suspension 375mg  MoH 2932 :
Form Granules for oral suspension
Packaging Bottle
Package Size 60ml
Strength 375mg/5ml
NSSF ✘
Quarantine ✘
Reg. Number 24790/79
Submission date 01/01/1979
Registration Year 1979
Archived Date 2018


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info